Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
Science Translational Medicine
|
June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
Tim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos Medicine
|
October 1, 2020
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, et al.
Breast Cancer Research : BCR
|
August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR
|
July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Med (New York, N.Y.)
|
May 19, 2022
Liquid biopsies for residual disease and recurrence
Jonathan Chee Ming Wan, Tariq Imdadali Mughal, Pedram Razavi, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
The New England Journal of Medicine
|
March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancer
Sarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2018
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Bente Risberg, Dana W Y Tsui, Heather Biggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
Nature
|
April 9, 2013
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza, Sarah-Jane Dawson, Dana W Y Tsui, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
Science Translational Medicine
|
June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
Tim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos Medicine
|
October 1, 2020
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, et al.
Breast Cancer Research : BCR
|
August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR
|
July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Med (New York, N.Y.)
|
May 19, 2022
Liquid biopsies for residual disease and recurrence
Jonathan Chee Ming Wan, Tariq Imdadali Mughal, Pedram Razavi, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
The New England Journal of Medicine
|
March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancer
Sarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
The Journal of Molecular Diagnostics : JMD
|
August 31, 2018
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Bente Risberg, Dana W Y Tsui, Heather Biggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
Nature
|
April 9, 2013
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza, Sarah-Jane Dawson, Dana W Y Tsui, et al.
Page
of 9